WCM Investment Management LLC Sells 40,589 Shares of HealthEquity, Inc. $HQY

WCM Investment Management LLC trimmed its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 17.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 193,371 shares of the company’s stock after selling 40,589 shares during the period. WCM Investment Management LLC’s holdings in HealthEquity were worth $15,756,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. William Blair Investment Management LLC purchased a new stake in HealthEquity in the fourth quarter worth approximately $169,956,000. Norges Bank purchased a new position in shares of HealthEquity during the fourth quarter worth approximately $66,927,000. AQR Capital Management LLC lifted its holdings in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after acquiring an additional 661,795 shares during the last quarter. Wasatch Advisors LP lifted its holdings in shares of HealthEquity by 9.3% in the 1st quarter. Wasatch Advisors LP now owns 7,202,934 shares of the company’s stock worth $601,949,000 after acquiring an additional 613,288 shares during the last quarter. Finally, Millennium Management LLC boosted its stake in shares of HealthEquity by 151.5% in the 4th quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock valued at $87,173,000 after purchasing an additional 573,283 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

HQY stock opened at $97.67 on Monday. The firm’s 50-day moving average price is $88.76 and its two-hundred day moving average price is $84.73. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $105.96. The stock has a market capitalization of $8.17 billion, a price-to-earnings ratio of 36.58, a PEG ratio of 1.64 and a beta of 0.21. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 3.92 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts recently commented on HQY shares. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research report on Monday, June 1st. BMO Capital Markets raised HealthEquity from a “market perform” rating to an “outperform” rating and raised their price objective for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Citigroup reiterated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wall Street Zen cut HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, July 4th. Finally, KeyCorp restated an “overweight” rating on shares of HealthEquity in a research report on Tuesday, May 26th. Eleven research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, HealthEquity presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.57.

Insider Buying and Selling at HealthEquity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,905 shares of company stock valued at $1,651,280 in the last 90 days. Insiders own 1.60% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.